Cover Image

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Saved in:
Bibliographic Details
Main Authors: Krämer, Isabelle (Author) , Stilgenbauer, Stephan (Author) , Dietrich, Sascha (Author) , Böttcher, Sebastian (Author) , Hegenbart, Ute (Author) , Ho, Anthony Dick (Author) , Dreger, Peter (Author)
Format: Article (Journal) Editorial
Language:English
Published: 21 September 2017
In: Blood
Year: 2017, Volume: 130, Issue: 12, Pages: 1477-1480
ISSN:1528-0020
DOI:10.1182/blood-2017-04-775841
Online Access:Resolving-System, Volltext: https://dx.doi.org/10.1182/blood-2017-04-775841
Get full text
Author Notes:Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, and Peter Dreger

MARC

LEADER 00000caa a2200000 c 4500
001 1031239618
003 DE-627
005 20220810050026.0
007 cr uuu---uuuuu
008 180924s2017 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2017-04-775841  |2 doi 
035 |a (DE-627)1031239618 
035 |a (DE-599)GBV1031239618 
035 |a (OCoLC)1340370640 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krämer, Isabelle  |d 1984-  |e VerfasserIn  |0 (DE-588)1025613481  |0 (DE-627)723627738  |0 (DE-576)370555724  |4 aut 
245 1 0 |a Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial  |c Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, and Peter Dreger 
246 3 3 |a To the editor: Allogeneic hematopoietic cell transplantation for high-risk CLL 
264 1 |c 21 September 2017 
300 |b Diagramme 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Letter to the editor 
500 |a "Letters to "Blood"" - Titelseite der Veröffentlichung 
700 1 |a Stilgenbauer, Stephan  |d 1966-  |e VerfasserIn  |0 (DE-588)114728380  |0 (DE-627)590333151  |0 (DE-576)302364781  |4 aut 
700 1 |a Dietrich, Sascha  |d 1979-  |e VerfasserIn  |0 (DE-588)136406300  |0 (DE-627)694354635  |0 (DE-576)301003408  |4 aut 
700 1 |a Böttcher, Sebastian  |d 1971-  |e VerfasserIn  |0 (DE-588)122679954  |0 (DE-627)705998363  |0 (DE-576)293377804  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 130(2017), 12, Seite 1477-1480  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial 
773 1 8 |g volume:130  |g year:2017  |g number:12  |g pages:1477-1480  |g extent:4  |a Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial 
856 4 0 |u https://dx.doi.org/10.1182/blood-2017-04-775841  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20200709 
993 |a Editorial 
994 |a 2017 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 16  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 136406300  |a Dietrich, Sascha  |m 136406300:Dietrich, Sascha  |d 910000  |d 910100  |e 910000PD136406300  |e 910100PD136406300  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1025613481  |a Krämer, Isabelle  |m 1025613481:Krämer, Isabelle  |d 910000  |d 910100  |e 910000PK1025613481  |e 910100PK1025613481  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1031239618  |e 3722810752 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Letter to the editor","\"Letters to \"Blood\"\" - Titelseite der Veröffentlichung"],"relHost":[{"pubHistory":["1.1946 -"],"language":["eng"],"part":{"issue":"12","extent":"4","pages":"1477-1480","text":"130(2017), 12, Seite 1477-1480","year":"2017","volume":"130"},"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"note":["Gesehen am 21.04.2023"],"corporate":[{"display":"American Society of Hematology","role":"isb"}],"id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]},"disp":"Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trialBlood","physDesc":[{"extent":"Online-Ressource"}],"recId":"266886647","origin":[{"dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"titleAlt":[{"title":"Blood online"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"physDesc":[{"noteIll":"Diagramme","extent":"4 S."}],"id":{"eki":["1031239618"],"doi":["10.1182/blood-2017-04-775841"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleAlt":[{"title":"To the editor: Allogeneic hematopoietic cell transplantation for high-risk CLL"}],"recId":"1031239618","origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"21 September 2017"}],"person":[{"given":"Isabelle","role":"aut","display":"Krämer, Isabelle","family":"Krämer"},{"family":"Stilgenbauer","display":"Stilgenbauer, Stephan","given":"Stephan","role":"aut"},{"family":"Dietrich","given":"Sascha","role":"aut","display":"Dietrich, Sascha"},{"given":"Sebastian","role":"aut","display":"Böttcher, Sebastian","family":"Böttcher"},{"role":"aut","given":"Ute","display":"Hegenbart, Ute","family":"Hegenbart"},{"family":"Ho","given":"Anthony Dick","role":"aut","display":"Ho, Anthony Dick"},{"family":"Dreger","given":"Peter","role":"aut","display":"Dreger, Peter"}],"name":{"displayForm":["Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, and Peter Dreger"]},"language":["eng"],"title":[{"title_sort":"Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial","title":"Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial"}]} 
SRT |a KRAEMERISAALLOGENEIC2120 

Similar Items